Stephanie Dunbar

Stephanie Dunbar has extensive experience in the pharmaceutical industry, with a focus on biostatistics and data sciences. Stephanie is currently serving as the Vice President and Head of Biometrics and RWE at Spark Therapeutics, Inc. Prior to this role, they held positions at AbbVie, ACADIA Pharmaceuticals Inc., Teva Pharmaceuticals, Bristol-Myers Squibb, Merck, GlaxoSmithKline, and DuPont Pharmaceuticals. Throughout their career, Stephanie has consistently held leadership roles, including Vice President and Head of Statistical Sciences and Analytics, Vice President of Biometrics, and Global Head of Biostatistics.

Stephanie Dunbar earned a Bachelor of Arts (BA) degree in Mathematics from the University of Massachusetts Dartmouth in 1995. Subsequently, they pursued a Doctor of Philosophy (PhD) in Statistics at the University of Virginia, completing the program in 2000.